/
/
/

CORONA Remedies Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)2,271.70
Volume (₹)2.01 L
High (₹)2,458.00
Upper Circuit2,725.90
Low (₹)2,271.70
Lower Circuit1,817.30
Prev Close2,271.60
52W High (₹)2,458.00
Price2,405.80
52W Low (₹)1,336.60

Share Market Cap & Key Ratios Overview

M.Cap (₹)13909.60 Cr
Div. Yield (%)0.44
PE Ratio67.19
Debt to Equity0.19
Price to Book12.74
Book Value122.12
EPS (TTM)33.85
Face Value10.00
ROE (%)27.36

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
CORONANSE
LTP
1W Low
1W High
Market cap (₹)
1773.4-4.3 (-0.24%)
1722
1810.40
4,25,150Cr
10037.5+257.5 (2.63%)
9863
10067
2,66,265Cr
4738.5+125.1 (2.71%)
4553
4738.50
1,76,301Cr
2323.8-81.7 (-3.40%)
2252.40
2441.90
1,25,352Cr
1188.1-57.4 (-4.61%)
1182.40
1266.60
1,23,591Cr
1374+22 (1.63%)
1336.70
1376.70
1,14,351Cr
1402+23.1 (1.68%)
1364.60
1402
1,12,474Cr
2537.9+45.1 (1.81%)
2457.90
2540
1,02,315Cr
1705+23.6 (1.40%)
1656.20
1724.60
97,757Cr
2008.6-2.4 (-0.12%)
1988.90
2062.10
92,007Cr
2405.8+256.2 (11.92%)
2104.20
2458
13,910Cr

Key Highlights of CORONA Remedies Ltd Balance Sheet

CORONA Remedies Ltd balance sheet discloses shareholders' funds of ₹61.16Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹61.16Cr, and the reserves and surplus of the company is ₹684.81Cr.

The company has its non-current liabilities with total liabilities of ₹1297.61Cr as of 2026-03-31.

The current liabilities are ₹454.53Cr as of 2026-03-31. At the same time, current assets are ₹441.67Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹25.4Cr and tangible assets of ₹553.97Cr, provided in the CORONA Remedies Ltd financial statements.